Clinical Trial

Migration in Total Hip Arthroplasty with a Cemented BiMobile Cup: Better Stability with More Cement?

Study acronym: Be-Mobile
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 28, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Objective: The main objective of this study is to compare the (early) migration of the cemented BiMobile cup at two year post-surgery between two different cup sizes after standard optimal reaming, and consequently adjusting the cement mantle into circa 2 or 4 mm, in patients with a primary cemented total hip arthroplasty (THA). Additionally, the results of the BiMobile cup will be compared to the Avantage cup, which is placed with a standard cup size, resulting in a cement mantle of approximately 2 mm. Study design: A prospective single centre blinded randomised controlled trial. Study population: All patients who meet the criteria to undergo a cemented THA.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-08-06; most recent amendment 2025-02-25.
Trial Details
NCT Number NCT04049279
Lead Sponsor JointResearch
Conditions Total Hip Arthroplasty, Osteoarthritis, Hip
Enrollment 75 participants
Start Date 2019-01-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-28